Development and prospect of clinical research on lung transplantation in post-COVID-19 era
10.3969/j.issn.1674-7445.2021.05.002
- VernacularTitle:后疫情时代的肺移植临床研究发展和未来展望
- Author:
Guohui JIAO
1
;
Jingyu CHEN
Author Information
1. Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi Lung Transplant Center, Jiangsu Lung Transplant Center, Wuxi 214000, China
- Publication Type:Research Article
- Keywords:
Lung transplantation;
Novel coronavirus pneumonia (COVID-19);
Acute respiratory distress syndrome (ARDS);
Extracorporeal membrane oxygenation (ECMO);
Ex vivo lung perfusion (EVLP);
Lung allocation score (LAS);
Organ allocation
- From:
Organ Transplantation
2021;12(5):506-
- CountryChina
- Language:Chinese
-
Abstract:
Lung transplantation has been advanced for nearly half a century around the globe, and it has been developed rapidly for over 20 years in China. The field of lung transplantation in China has been gradually integrated into the international community. The outbreak of novel coronavirus pneumonia (COVID-19) in 2020 brought big challenges, as well as diverted the worldwide attention to the development of lung transplantation in China, accelerating international communication and cooperation. With the steadily deepening of clinical and basic research on lung transplantation for severe cases of COVID-19, organ transplant physicians have deepened the understanding and thinking of the maintenance of donors, selection of elderly and pediatric candidates, and perioperative management of recipients, as the future perspective of lung transplantation in China. For interdisciplinary research related to lung transplantation, it is necessary to carry out multi-center clinical trials with qualified study design and constantly promote the theoretic and practical innovation.
